Default company panoramic image
94563162 c120 48e7 9b29 8a8e9594293c

Avaxia Biologics, Inc.

Avaxia Biologics develops orally-delivered antibody products for disease targets accessible via the GI tract.

  • Stage Not Set
  • Industry Biotechnology
  • Location Burlington, MA, USA
  • Currency USD
  • Employees 3
  • Website avaxiabiologics.com

Company Summary

Team

  • Default avatar
    Barbara Fox
    CEO

  • Default avatar
    Anne Baia
    CFO

  • Default avatar
    Eileen Bostwick
    VP Product Development

Advisors

  • Default avatar
    Lewis Geffen, MintzLevin; Darlene Vanstone, Elmore Patent Group
    Lawyer
    Unconfirmed

Previous Investors

  • Default avatar
    Jonathan Fleming |David Poorvin, PhD|Management, other individuals
    Unconfirmed